Tufts CSDD Study Identifies Opportunities for Drug Sponsors

Published on: 

Applied Clinical Trials

Conducted in collaboration with The Avoca Group, based on an analysis of data provided by 76 varied sized pharmaceutical companies engaged in global drug development, a newly completed study from the Tufts Center for the Study of Drug Development says large sponsors have significantly longer and more variable process completion-to-contract stages than other companies.

For more from the study, click here.